Comparison of Optic Coherence Tomography Findings of Chronic Renal Failure and Renal Transplant Patients

Objective: To compare the Spectral-Domain Optic Coherence Tomography (SD-OCT) findings of chronic renal failure (CRF) and renal transplant (RTx) patients. Methods: Sixty eyes of thirty patients with CRF and 60 eyes of thirty RTx patients were enrolled in the study. A thorough ophthalmologic examination was applied to each patient, including the following parameters: best-corrected visual acuity (BCVA), intraocular pressure (IOP), anterior and posterior segment examination, central corneal thickness (CCT), retinal nerve fiber layer thickness (RNFLT), foveal thickness (FT), and choroid thickness (ChT) measurements. Results: Distribution of the primary disease, gender and the median duration of RTx and CRF (18 and 36 months respectively, p=0.390) were similar between the groups, and the difference was not significant. The mean age of patients in the CRF group was statistically higher than that of the RTx group (57.5±10.6 and 44.4±11.9 years respectively, p

Keywords:

choroid thickness foveal thickness; renal failure, renal transplantation; retinal nerve fiber layer thickness,

PDF

___

1.Bajracharya L, Shah DN, Raut KB, Koirala S. Ocularevaluation in patients with chronic renal failure–ahospital based study. Nepal Med Coll J. 2008; 10(4):209–14.
2.Duman E, Kal Ö, Kal A. Evaluation of the ocularblood flow and choroidal thickness in patients withchronic renal failure. Medeniyet Medical Journal2017; 32(4): 245-9.
3.Raczynska D, Slizien M, Bzoma B, et al. A 10-yearmonitoring of the eyesight in patients after kidneytransplantation. Medicine. 2018; 97:1-6
4.Çıtırık M, İlhan Ç, Teke MY. Optik KoherensTomografi. Güncel Retina 2017; 1(1): 58-68.
5.Yu DY, Yu PK, Cringle SJ, Kang MH, Su EN.Functional and morphological characteristics of theretinal and choroidal vasculature. Prog Retin EyeRes. 2014; 40: 53–93.
6.Usui S, Ikuno Y, Akiba M, et al. Circadian changesin subfoveal choroidal thickness and therelationship with circulatory factors in healthysubjects. Invest Ophthalmol Vis Sci. 2012; 53(4):2300–7.
7.Chelala E, Dirani A, Fadlallah A, et al. Effect ofhemodialysis on visual acuity, intraocular pressure,and macular thickness in patients with chronickidney disease. Clin Ophthalmol. 2015; 9: 109– 14.
8.Yang SJ, Han YH, Song GI, Lee CH, Sohn SW.Changes of choroidal thickness, intraocular pressure and other optical coherence tomographicparameters after haemodialysis. Clin Exp Optom.2013; 96: 494–9.
9.Ulas F, Dogan U, Keles A, et al. Evaluation ofchoroidal and retinal thickness measurements using optical coherence tomography in nondiabetichaemodialysis patients. Int Ophthalmol. 2013; 33:533–9.
10.Durlik M, Zaniewicz K. Bzoma B, et al.Recommendations for immunosuppressivetreatment after solid organ transplantation.Medicine. 2018; 97(6): e9822-e9830.
11.Hwang H, Chae JB, Kim JY, Moon BG, Kim DY.Changes in optical coherence tomography findings in patients with chronic renal failure undergoing dialysis for the first time. Retina. 2019; 39(12): 2360-8.
12.Chang B, Lee JH, Kim JS. Changes in Choroidalthickness in and outside the macula afterhemodialysis in patients with end-stage renaldisease. Retina. 2017; 37: 896–905.
13.Regatieri CV, Ba BL, Carmody J, Fujimoto JG,Duker JS. Choroidal thickness in patients withdiabetic retinopathy analyzed by spectral-domainoptical coherence tomography. Retina. 2012; 32(3):563–8.
14.Ishibazawa A, Nagaoka T, Minami Y, et al.Choroidal thickness evaluation before and afterhemodialysis in patients with and without diabetes.Invest Ophthalmol Vis Sci. 2015; 56: 6534–6541.
15.Shin YU, Lee SE, Kang MH, et al. Evaluation ofchanges in choroidal thickness and the choroidalvascularity index after hemodialysis in patients with end-stage renal disease by using swept-sourceoptical coherence tomography. Medicine. 2019;98(18): e15421-e15428.
16.Atilgan CU, Guven D, Akarsu OP, et al. Effects ofhemodialysis on macular and retinal nerve fiberlayer thicknesses in non-diabetic patients with endstage renal failure. Saudi Med J. 2016; 37(6): 641-7.
17.Paterson EN, Ravindran ML, Griffiths K, et al.Association of reduced inner retinal thicknesseswith chronic kidney disease. BMC Nephrolog. 2020; 21: 37-48.
18.Jeon SJ, Park H-Y L, Lee JH, Park CK. Relationshipbetween systemic vascular characteristics andretinal nerve fiber layer loss in patients with type 2diabetes. Scientific Reports. 2018; 8: 10510-7.
19.Chen H, Zhang X, Shen Xi. Ocular changes duringhemodialysis in patients with end-stage renaldisease. BMC Ophthalmology. 2018; 18: 208-17.
20. Shin Y, Lee J, Lee CJ, Park S, Byeon SH. Associationbetween localised retinal nerve fibre layer defectsand cardiovascular risk factors. Scientific Reports.2019; 9: 19340-7.
21.Rougier MB, Korobelnik JF, Malet F, et al. Retinalnerve fibre layer thickness measured with SD-OCTin a population-based study of French elderlysubjects: the Alienor study. Acta Ophthalmol. 2015;93: 539–45.
22.Li D, Rauscher FG, Choi EY, et al. Sex-specificdifferences in circumpapillary retinal nerve fiberlayer thickness. Ophthalmology. 2020; 127(3): 357–68.
23.Kırıkkaya E, Menteş J, Erakgün T. Macularthickness and retinal nerve fiber layer thicknessmeasurements with optic coherence tomography inpatients with type 1 and type 2 diabetes mellituswithout retinopathy. Ret-Vit. 2010; 18:297-304.